Cytiva And Pall Corp. Invest $1.5 Bln To Meet Growing Demand For Biotechnology

Cytiva and Pall Corpor., part of the Danaher (DHR) Corp., said that they will expand manufacturing capacity and services across geographies for global life sciences customers.

The companies will invest about $1.5 billion over two years to meet growing demand for biotechnology solutions, Cytiva said in a statement.

Major investments are expanding manufacturing capacity for life sciences products at 13 Cytiva and Pall Corp. sites helping to meet customer demand.

The investment follows five strategic acquisitions made by the companies this year and is in addition to Cytiva's continuing capacity investments estimated at $500 million through 2022.

New sites opening in US and UK will realize regional manufacturing models. Overall, the companies plan to hire 2000 full-time associates over the next two years, Cytiva said.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The Goldman Sachs Group, Inc. (GS) reported that its third quarter net earnings applicable to common shareholders increased 63 percent year-on-year. Net revenues were also significantly higher reflecting significantly higher net revenues in Investment Banking, Global Markets and Consumer & Wealth Management,... Butterball, LLC recalled about 14,107 pounds of ground turkey products for potential contamination with foreign materials, specifically blue plastic material, the U.S. Department of Agriculture's Food Safety and Inspection Service (FSIS) said in a statement. Specialized Bicycle Components, Inc. is recalling about 6,900 units of Tarmac SL7 Bicycles and Framesets for potential risk of fall and injury hazard, a statement by the U.S. Consumer Product Safety Commission (CPSC) showed. The company said the bicycle's fork steerer tube can crack or break after harsh impact such as hitting a deep pothole or other stress event, posing fall and injury hazards.
Follow RTT